The use of platelet-rich plasma (PRP) in urology
https://doi.org/10.21886/2308-6424-2023-11-1-134-142
Abstract
Platelet-rich plasma (PRP) is one of the most common and practicable plasma-therapy techniques. The wide therapeutic range for the use of this technique in various medical fields is due to its high content of growth factors, cytokines, and chemokines. The property of PRP to induce tissue regeneration is particularly highlighted, which is used actively for the treatment of a broad range of urological diseases. The review aimed to highlight the accumulated material on the topic of the use of autologous biomaterials based on blood in urology. This article highlights the urgent need for further study of the prospects for the use of autoplasma technologies in wide multicenter studies.
About the Authors
S. V. Popov
St. Luke St. Petersburg Clinical Hospital;
Kirov Military Medical Academy
Russian Federation
Russian Federation
Sergey V. Popov — M.D., Dr.Sc. (Med), Full Prof.; Chief Medical Officer, Head, Municipal Centre of Endoscopic Urology and New Technologies;
Prof., Dept. of Urology,
St. Petersburg
I. N. Orlov
St. Luke St. Petersburg Clinical Hospital;
Mechnikov North-Western State Medical University
Russian Federation
Russian Federation
Igor N. Orlov — M.D., Cand.Sc.(Med); Deputy Chief Medical Officer for Medical;
Assist.Prof., Dept. of Urology,
St. Petersburg
T. M. Topuzov
St. Luke St. Petersburg Clinical Hospital
Russian Federation
Russian Federation
Timur M. Topuzov — M.D., Cand.Sc. (Med); Head, Urology Division No.1, Municipal Centre of Endoscopic Urology and New Technologies,
M. L. Gorelik
St. Luke St. Petersburg Clinical Hospital;
Mechnikov North-Western State Medical University
Russian Federation
Russian Federation
Maksim L. Gorelik — Resident, Urology Division No.1, Municipal Centre of Endoscopic Urology and New Technologies,
M. A. Perfil’yev
St. Luke St. Petersburg Clinical Hospital;
Mechnikov North-Western State Medical University
Russian Federation
Russian Federation
Mark A. Perfil’yev — Resident, Urology Division No.1, St. Petersburg of Endoscopic Urology and New Technologies,
M. A. Kotlov
St. Luke St. Petersburg Clinical Hospital;
Mechnikov North-Western State Medical University
Russian Federation
Russian Federation
Mikhail A. Kotlov — Student,
St. Petersburg
References
1. Gigante A, Del Torto M, Manzotti S, Cianforlini M, Busilacchi A, Davidson PA, Greco F, Mattioli-Belmonte M. Platelet rich fibrin matrix effects on skeletal muscle lesions: an experimental study. J Biol Regul Homeost Agents. 2012;26(3):475-84. PMID: 23034267
2. Kushida S, Kakudo N, Morimoto N, Hara T, Ogawa T, Mitsui T, Kusumoto K. Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems. J Artif Organs. 2014;17(2):186-92. DOI: 10.1007/s10047-014-0761-5
3. Xie X, Zhang C, Tuan RS. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther. 2014;16(1):204. DOI: 10.1186/ar4493
4. Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med. 2008;1(3-4):165-74. DOI: 10.1007/s12178-008-9032-5
5. Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol. 2013;9(12):721-30. DOI: 10.1038/nrrheum.2013.141
6. Jiritano F, Serraino GF, Cristodoro L, Renzulli A. Ventricular assist device abdominal driveline infection: treatment with platelet-rich plasma. J Thorac Cardiovasc Surg. 2013;145(6):e69-70. DOI: 10.1016/j.jtcvs.2013.02.072
7. Marck RE, Middelkoop E, Breederveld RS. Considerations on the use of platelet-rich plasma, specifically for burn treatment. J Burn Care Res. 2014;35(3):219-27. DOI: 10.1097/BCR.0b013e31829b334e
8. Schiavone G, Raskovic D, Greco J, Abeni D. Platelet-rich plasma for androgenetic alopecia: a pilot study. Dermatol Surg. 2014;40(9):1010-9. DOI: 10.1097/01.DSS.0000452629.76339.2b
9. Zhou B, Ren J, Ding C, Wu Y, Chen J, Wang G, Gu G, Li J. Protection of colonic anastomosis with platelet-rich plasma gel in the open abdomen. Injury. 2014;45(5):864-8. DOI: 10.1016/j.injury.2014.01.018
10. Galliera E, Corsi MM, Banfi G. Platelet rich plasma therapy: inflammatory molecules involved in tissue healing. J Biol Regul Homeost Agents. 2012;26(2 Suppl 1):35S-42S. PMID: 23648197
11. Randelli P, Randelli F, Ragone V, Menon A, D'Ambrosi R, Cucchi D, Cabitza P, Banfi G. Regenerative medicine in rotator cuff injuries. Biomed Res Int. 2014;2014:129515. DOI: 10.1155/2014/129515
12. Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front Biosci. 2008;13:3532-48. DOI: 10.2741/2947
13. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83(3):835-70. DOI: 10.1152/physrev.2003.83.3.835
14. Chatterjee US, Mandal MK, Basu S, Das R, Majhi T. Comparative study of dartos fascia and tunica vaginalis pedicle wrap for the tubularized incised plate in primary hypospadias repair. BJU Int. 2004;94(7):1102-4. DOI: 10.1111/j.1464-410X.2004.05111.x
15. Soygur T, Arikan N, Zumrutbas AE, Gulpinar O. Snodgrass hypospadias repair with ventral based dartos flap in combination with mucosal collars. Eur Urol. 2005;47(6):879- 84; discussion 884. DOI: 10.1016/j.eururo.2005.02.022
16. Mahmoud AY, Gouda S, Gamaan I, Baky Fahmy MA. Autologous platelet-rich plasma covering urethroplasty versus dartos flap in distal hypospadias repair: A prospective randomized study. Int J Urol. 2019;26(4):475-480. DOI: 10.1111/iju.13912
17. Antoniades HN, Williams LT. Human platelet-derived growth factor: structure and function. Fed Proc. 1983;42(9):2630-4. PMID: 6303866
18. Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun. 2002;70(12):6524-33. DOI: 10.1128/IAI.70.12.6524-6533.2002
19. Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997;55(11):1294-9. DOI: 10.1016/s0278-2391(97)90187-7
20. Braccini F, Tardivet L, Dohan Ehrenfest DM. Place des facteurs de croissance (Platelet-Rich Fibrin de Choukroun) dans la chirurgie de l'oreille moyenne: résultats préliminaires [The relevance of Choukroun's PlateletRich Fibrin (PRF) during middle ear surgery: preliminary results]. Rev Laryngol Otol Rhinol (Bord). 2009;130(3):175-80. (In French). PMID: 20345074
21. Mishra A, Woodall J Jr, Vieira A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med. 2009;28(1):113-25. DOI: 10.1016/j.csm.2008.08.007
22. Scarcia M, Maselli FP, Cardo G, Ludovico GM. The use of autologous platelet rich plasma gel in bulbar and penile buccal mucosa urethroplasty: Preliminary report of our first series. Arch Ital Urol Androl. 2016;88(4):274-278. DOI: 10.4081/aiua.2016.4.274
23. Gül M, Altıntaş E, Kaynar M, Buğday MS, Göktaş S. The predictive value of platelet to lymphocyte and neutrophil to lymphocyte ratio in determining urethral stricture after transurethral resection of prostate. Turk J Urol. 2017;43(3):325-329. DOI: 10.5152/tud.2017.14478
24. Rothan HA, Djordjevic I, Bahrani H, Paydar M, Ibrahim F, Abd Rahmanh N, Yusof R. Three-dimensional culture environment increases the efficacy of platelet rich plasma releasate in prompting skin fibroblast differentiation and extracellular matrix formation. Int J Med Sci. 2014;11(10):1029-38. DOI: 10.7150/ijms.8895
25. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331(19):1286-92. DOI: 10.1056/NEJM199411103311907
26. Sangkum P, Gokce A, Tan RB, Bouljihad M, Kim H, Mandava SH, Saleem SN, Lasker GF, Yafi FA, Abd Elmageed ZY, Moparty K, Sikka SC, Abdel-Mageed AB, Hellstrom WJ. Transforming Growth Factor-β1 Induced Urethral Fibrosis in a Rat Model. J Urol. 2015;194(3):820-7. DOI: 10.1016/j.juro.2015.02.014
27. Rezaei M, Badiei R, Badiei R. The effect of platelet-rich plasma injection on post-internal urethrotomy stricture recurrence. World J Urol. 2019;37(9):1959-1964. DOI: 10.1007/s00345-018-2597-8
28. Iricjan M.M, Kotov S.V., Klimenko A.A. Primenenie plazmy, obogashhennoj trombocitami pri uretroplastike s cel'ju profilaktiki povtornogo recidiva striktury uretry. Cardiovascular therapy and prevention. 2021;20(S1):36-37. (In Russian). eLIBRARY ID: 45556754; EDN: XMOKDH
29. Medvedev V.L., Opolsky M.A., Kogan M.I. Clinical effectiveness of complex treatment vesicovaginal fistula using of the platelet reach autoplasma, compared to standard approach to fistuloplasty. Experimental and Сlinical Urology. 2019;(2):158-163. (In Russian). DOI: 10.29188/2222-8543-2019-11-2-158-162.
30. Jhang JF, Wu SY, Lin TY, Kuo HC. Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study. Low Urin Tract Symptoms. 2019;11(2):O42-O47. DOI: 10.1111/luts.12212
31. ME, Grigorjan VA, Epifanova MV, Krasnov AO. [The effectiveness of intracavernous autologous platelet-rich plasma in the treatment of erectile dysfunction]. Urologiia. 2015;(4):76-9. (In Russian). PMID: 26665770
32. Glybochko PV, Chaly ME, Yepifanova MV, Akhvlediani ND, Krasnov AO. [Application of autoplasma enriched with platelet derived growth factor in the treatment of erectile dysfunction]. Urologiia. 2015;(1):100-3. (In Russian). PMID: 26094397
33. Epifanova M.V., Chalyi M.E., Krasnov A.O. Investigation of mechanisms of action of growth factors of autologous platelet-rich plasma used to treat erectile dysfunction. Urologiia. 2017;(4):46-48. (In Russian). DOI: 10.18565/urol.2017.4.46-48
34. Banno JJ, Kinnick TR, Roy L, Perito P, Antonini G, Banno D. 146 The Efficacy of Platelet-Rich Plasma (PRP) as a Supplemental Therapy for the Treatment of Erectile Dysfunction (ED): Initial Outcomes. The Journal of Sexual Medicine. 2017;14(2):e59–e60. DOI: 10.1016/j.jsxm.2016.12.134
35. Alkhayal S, Lourdes M. 320 Corporeal rejuvenation with platelet rich plasma as a treatment for erectile dysfunction. The Journal of Sexual Medicine. 2018;15(7):S254. DOI: 10.1016/j.jsxm.2018.04.283
36. Matz EL, Pearlman AM, Terlecki RP. Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions. Investig Clin Urol. 2018;59(1):61-65. DOI: 10.4111/icu.2018.59.1.61
Review
For citations:
Popov S.V., Orlov I.N., Topuzov T.M., Gorelik M.L., Perfil’yev M.A., Kotlov M.A. The use of platelet-rich plasma (PRP) in urology. Urology Herald. 2023;11(1):134-142. (In Russ.) https://doi.org/10.21886/2308-6424-2023-11-1-134-142
Views:
4496
Email this article 
